Show simple item record

dc.contributor.authorKeene, C
dc.contributor.authorMohr-Holland, E
dc.contributor.authorCassidy, T
dc.contributor.authorScott, V
dc.contributor.authorNelson, A
dc.contributor.authorFurin, J
dc.contributor.authorTrivino-Duran, L
dc.date.accessioned2020-10-06T23:57:02Z
dc.date.available2020-10-06T23:57:02Z
dc.date.issued2020-08-03
dc.date.submitted2020-10-06
dc.identifier.pmid32758439
dc.identifier.doi10.1016/S2213-2600(20)30311-8
dc.identifier.urihttp://hdl.handle.net/10144/619727
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.rightsWith thanks to Elsevier.en_US
dc.titleHow COVID-19 could benefit tuberculosis and HIV services in South Africa.en_US
dc.typeArticle
dc.identifier.eissn2213-2619
dc.identifier.journalThe Lancet. Respiratory Medicineen_US
dc.source.journaltitleThe Lancet. Respiratory medicine
dc.source.volume8
dc.source.issue9
dc.source.beginpage844
dc.source.endpage846
refterms.dateFOA2020-10-06T23:57:04Z
dc.source.countryEngland


Files in this item

Thumbnail
Name:
Keene et al 2020 How COVID-19 ...
Size:
298.8Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record